[Form 4] Doximity, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Kira Scherer Wampler, a director of Doximity, Inc. (DOCS), was granted 3,221 restricted stock units (RSUs) on 08/28/2025 under the company's non-employee director compensation policy. Each RSU represents a contingent right to one share of the issuer's Class A Common Stock and the award vests in full on the earlier of the first anniversary of the grant date or the issuer's next annual meeting of stockholders, subject to continued service as a director.

Following the reported grant, the reporting person beneficially owns 19,839 shares of Class A Common Stock. The Form 4 was submitted with a signature by an attorney-in-fact on 09/02/2025.

Positive

• Director alignment: Grant of 3,221 RSUs ties the director's compensation to company equity, aligning interests with shareholders
• Clear vesting terms: RSUs vest on the earlier of one year or the next annual meeting, providing transparent, time-based incentives
• Disclosure completeness: Form 4 reports post-grant beneficial ownership of 19,839 shares and includes signature via attorney-in-fact

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine director equity grant; modest increase in insider holdings, no cash transaction disclosed.

The filing documents a standard non-employee director award of 3,221 RSUs that convert 1:1 to Class A shares upon vesting. This is a compensation-related issuance rather than a market purchase or sale, and the reported post-grant beneficial ownership is 19,839 shares. There is no cash price paid and no derivative instruments reported. For investors, this is a governance/compensation disclosure rather than a signal of transactional market activity.

Corporate Governance Expert

TL;DR: Typical director compensation mechanics with time-based vesting tied to continued service.

The award follows the issuer's non-employee director compensation policy and vests based on service or the next annual meeting, which aligns director incentives with shareholder alignment over a short-term horizon. The Form 4 properly discloses the contingent nature of the RSUs and reports direct beneficial ownership. There are no governance red flags or unusual terms disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wampler Kira Scherer

(Last) (First) (Middle)

C/O DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/28/2025		A		3,221(1)	A	$0	19,839	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units (each, an "RSU") granted on August 28, 2025 pursuant to the Issuer's non-employee director compensation policy, which vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Remarks:

	/s/ Anna Bryson, Attorney-in-Fact	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filing for DOCS disclose?

The filing discloses a grant of 3,221 RSUs to director Kira Scherer Wampler on 08/28/2025, and post-grant beneficial ownership of 19,839 Class A shares.

When do the RSUs granted to the DOCS director vest?

The RSUs vest in full on the earlier of (i) the first anniversary of the grant date or (ii) Doximity's next annual meeting of stockholders, subject to continued service.

Did the reporting person pay cash for the RSUs in the DOCS Form 4?

No cash price is disclosed; the transaction is reported with a price of $0, indicating a compensatory RSU grant.

How many shares does the reporting person beneficially own after the reported transaction?

The Form 4 reports beneficial ownership of 19,839 shares of Class A Common Stock following the grant.

Who signed the Form 4 for the DOCS filing?

The filing shows a signature by /s/ Anna Bryson, Attorney-in-Fact dated 09/02/2025.